Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
7.74
USD
-1.65%
Market Closed
Market Cap:
$601.8m
Balance Sheet
Balance Sheet Decomposition
Chromadex Corp
Chromadex Corp
Balance Sheet Decomposition is not available for
Chromadex Corp
Chromadex Corp
Balance Sheet
Chromadex Corp
Chromadex Corp
Currency: USD
| Jan-2016 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6
|
2
|
45
|
23
|
19
|
17
|
28
|
20
|
27
|
45
|
|
| Cash |
6
|
2
|
45
|
23
|
19
|
17
|
28
|
20
|
27
|
45
|
|
| Total Receivables |
2
|
6
|
5
|
5
|
2
|
3
|
5
|
8
|
5
|
8
|
|
| Accounts Receivables |
2
|
6
|
5
|
4
|
1
|
2
|
3
|
5
|
2
|
8
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
0
|
|
| Inventory |
8
|
8
|
6
|
8
|
12
|
12
|
14
|
15
|
15
|
9
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
|
| Total Current Assets |
17
|
16
|
57
|
37
|
34
|
32
|
49
|
47
|
50
|
64
|
|
| PP&E Net |
2
|
3
|
3
|
4
|
5
|
4
|
7
|
6
|
5
|
3
|
|
| PP&E Gross |
2
|
3
|
3
|
4
|
5
|
4
|
7
|
0
|
5
|
3
|
|
| Accumulated Depreciation |
3
|
3
|
1
|
2
|
3
|
4
|
5
|
0
|
5
|
6
|
|
| Intangible Assets |
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Note Receivable |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Total Assets |
19
N/A
|
20
+5%
|
63
+218%
|
42
-33%
|
40
-5%
|
38
-5%
|
58
+51%
|
54
-7%
|
55
+2%
|
68
+24%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6
|
6
|
4
|
10
|
10
|
9
|
10
|
10
|
10
|
9
|
|
| Accrued Liabilities |
1
|
2
|
4
|
4
|
5
|
7
|
7
|
8
|
10
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
10
|
9
|
8
|
14
|
15
|
16
|
18
|
18
|
21
|
18
|
|
| Long-Term Debt |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
5
|
5
|
9
|
7
|
6
|
4
|
|
| Total Liabilities |
13
N/A
|
10
-27%
|
9
-9%
|
15
+69%
|
20
+32%
|
22
+11%
|
26
+19%
|
25
-3%
|
27
+4%
|
22
-16%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
42
|
45
|
57
|
90
|
122
|
142
|
169
|
185
|
190
|
182
|
|
| Additional Paid In Capital |
47
|
55
|
110
|
117
|
142
|
158
|
201
|
214
|
219
|
228
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
10
+89%
|
54
+440%
|
27
-50%
|
20
-25%
|
16
-20%
|
32
+93%
|
29
-10%
|
28
-1%
|
46
+62%
|
|
| Total Liabilities & Equity |
19
N/A
|
20
+5%
|
63
+218%
|
42
-33%
|
40
-5%
|
38
-5%
|
58
+51%
|
54
-7%
|
55
+2%
|
68
+24%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
36
|
38
|
55
|
55
|
60
|
62
|
68
|
75
|
75
|
77
|
|
Switch to:
Switch to:
See Also
Discover More
